Called to the Bar
  • Ontario (2022)
  • Alberta (2021)
Education
  • JD, University of Calgary, 2020
  • MSc, Chemistry, University of British Columbia, 2015
  • BSc, Chemistry, Saint Mary’s University, 2012

Amber Blair is an Associate in the Commercial Litigation, Fraud and Anti-Corruption, Blockchain and Digital Assets Practice Groups at WeirFoulds LLP.

Amber’s practice spans a broad range of complex commercial disputes, including fraud, injunctions, asset tracing and recovery, enforcement of foreign judgments and arbitral awards, and cryptocurrency disputes. She has acted on complex, high-value matters involving sophisticated commercial, financial technology, intellectual property, and construction issues, including disputes concerning significant assets and business interests. Amber is known for her calm approach, sharp analytical skills, and practical, result-oriented advocacy. Her priority is always to achieve the best possible outcome for her clients in an efficient and thoughtful way.

Prior to joining WeirFoulds LLP, Amber practiced for several years at an elite commercial litigation firm in Toronto, where she maintained a diverse commercial litigation, intellectual property litigation, and construction litigation practice. She has acted for clients ranging from emerging companies to multinational corporations in complex commercial and intellectual property disputes and has appeared in proceedings before the Federal Court on motions and at trial.

Experience
  • Acting for a family investment and consulting business in an action arising from a series of sophisticated cryptocurrency investment and recovery scams and seeking to recover CAD $20 million.
  • Acting for a private jet brokerage in proceedings involving the investigation and recovery of cryptocurrency and US funds.
  • Acting for a pharmaceutical company in a patent infringement action involving two patents relating to biologic medication used to treat chronic inflammatory and autoimmune diseases.
  • Acting for a construction and mining equipment dealer in a complex commercial dispute arising from the sale of a dealership.
  • Acting for one of Canada’s largest infrastructure companies in proceedings relating to the construction of sewer systems and overland drainage infrastructure.
  • Acting for a digital entertainment technology company in a patent infringement action involving four patents relating to digital entertainment technologies.
  • Acting for a leading biopharmaceutical company in four Notice of Compliance proceedings involving two Canadian patents relating to medication used in antiretroviral therapy and pre-exposure prophylaxis.
  • Acting for a multinational technology company in a patent infringement action involving two patents relating to cellular communications technology.
  • Acting for a multinational pharmaceutical company in a patent infringement action involving two patents relating to antipsychotic medication used to treat schizophrenia and bipolar disorder.
  • Acting for a family investment and consulting business in an action arising from a series of sophisticated cryptocurrency investment and recovery scams and seeking to recover CAD $20 million.
  • Acting for a private jet brokerage in proceedings involving the investigation and recovery of cryptocurrency and US funds.
  • Acting for a pharmaceutical company in a patent infringement action involving two patents relating to biologic medication used to treat chronic inflammatory and autoimmune diseases.
  • Acting for a construction and mining equipment dealer in a complex commercial dispute arising from the sale of a dealership.
  • Acting for one of Canada’s largest infrastructure companies in proceedings relating to the construction of sewer systems and overland drainage infrastructure.
  • Acting for a digital entertainment technology company in a patent infringement action involving four patents relating to digital entertainment technologies.
  • Acting for a leading biopharmaceutical company in four Notice of Compliance proceedings involving two Canadian patents relating to medication used in antiretroviral therapy and pre-exposure prophylaxis.
  • Acting for a multinational technology company in a patent infringement action involving two patents relating to cellular communications technology.
  • Acting for a multinational pharmaceutical company in a patent infringement action involving two patents relating to antipsychotic medication used to treat schizophrenia and bipolar disorder.

Amber Blair is an Associate in the Commercial Litigation, Fraud and Anti-Corruption, Blockchain and Digital Assets Practice Groups at WeirFoulds LLP.

Amber’s practice spans a broad range of complex commercial disputes, including fraud, injunctions, asset tracing and recovery, enforcement of foreign judgments and arbitral awards, and cryptocurrency disputes. She has acted on complex, high-value matters involving sophisticated commercial, financial technology, intellectual property, and construction issues, including disputes concerning significant assets and business interests. Amber is known for her calm approach, sharp analytical skills, and practical, result-oriented advocacy. Her priority is always to achieve the best possible outcome for her clients in an efficient and thoughtful way.

Prior to joining WeirFoulds LLP, Amber practiced for several years at an elite commercial litigation firm in Toronto, where she maintained a diverse commercial litigation, intellectual property litigation, and construction litigation practice. She has acted for clients ranging from emerging companies to multinational corporations in complex commercial and intellectual property disputes and has appeared in proceedings before the Federal Court on motions and at trial.

Experience
  • Acting for a family investment and consulting business in an action arising from a series of sophisticated cryptocurrency investment and recovery scams and seeking to recover CAD $20 million.
  • Acting for a private jet brokerage in proceedings involving the investigation and recovery of cryptocurrency and US funds.
  • Acting for a pharmaceutical company in a patent infringement action involving two patents relating to biologic medication used to treat chronic inflammatory and autoimmune diseases.
  • Acting for a construction and mining equipment dealer in a complex commercial dispute arising from the sale of a dealership.
  • Acting for one of Canada’s largest infrastructure companies in proceedings relating to the construction of sewer systems and overland drainage infrastructure.
  • Acting for a digital entertainment technology company in a patent infringement action involving four patents relating to digital entertainment technologies.
  • Acting for a leading biopharmaceutical company in four Notice of Compliance proceedings involving two Canadian patents relating to medication used in antiretroviral therapy and pre-exposure prophylaxis.
  • Acting for a multinational technology company in a patent infringement action involving two patents relating to cellular communications technology.
  • Acting for a multinational pharmaceutical company in a patent infringement action involving two patents relating to antipsychotic medication used to treat schizophrenia and bipolar disorder.
  • Acting for a family investment and consulting business in an action arising from a series of sophisticated cryptocurrency investment and recovery scams and seeking to recover CAD $20 million.
  • Acting for a private jet brokerage in proceedings involving the investigation and recovery of cryptocurrency and US funds.
  • Acting for a pharmaceutical company in a patent infringement action involving two patents relating to biologic medication used to treat chronic inflammatory and autoimmune diseases.
  • Acting for a construction and mining equipment dealer in a complex commercial dispute arising from the sale of a dealership.
  • Acting for one of Canada’s largest infrastructure companies in proceedings relating to the construction of sewer systems and overland drainage infrastructure.
  • Acting for a digital entertainment technology company in a patent infringement action involving four patents relating to digital entertainment technologies.
  • Acting for a leading biopharmaceutical company in four Notice of Compliance proceedings involving two Canadian patents relating to medication used in antiretroviral therapy and pre-exposure prophylaxis.
  • Acting for a multinational technology company in a patent infringement action involving two patents relating to cellular communications technology.
  • Acting for a multinational pharmaceutical company in a patent infringement action involving two patents relating to antipsychotic medication used to treat schizophrenia and bipolar disorder.
Called to the Bar
  • Ontario (2022)
  • Alberta (2021)
Education
  • JD, University of Calgary, 2020
  • MSc, Chemistry, University of British Columbia, 2015
  • BSc, Chemistry, Saint Mary’s University, 2012
Latest Insight & News